Parisi Gray Wealth Management Supernus Pharmaceuticals, Inc. Transaction History

Parisi Gray Wealth Management

  • $301 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$23.54 - $31.39 $1,224 - $1,632
-52 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$26.72 - $33.19 $1,389 - $1,725
52 New
52 $2,000
Q2 2019

Jul 19, 2019
SELL
$29.96 - $38.87 $4,763 - $6,180
-159 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$36.4 - $42.6 $5,787 - $6,773
159
159 $6,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.96B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Parisi Gray Wealth Management Portfolio

Follow Parisi Gray Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parisi Gray Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Parisi Gray Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email